Biopharmaceutical company developing novel therapies for rare respiratory diseases
Kither Biotech has raised €19M across 1 funding round from 9 investors, most recently a Series B round in Mar 2022. Based in Turin, Italy; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-03-29 | Series B | €19M |
| 2 Invest,3B Future Health Fund,ACE Ventures,Alef 6,CDP Venture Capital,Claris Ventures+3 more |
| View deal → |
